| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41591-018-0021-Y |
| P698 | PubMed publication ID | 29808008 |
| P50 | author | Hannelore Ehrenreich | Q1575862 |
| Andrew E Jaffe | Q48184728 | ||
| Giuseppe Blasi | Q55999215 | ||
| Marina Mitjans | Q57015626 | ||
| Ryota Hashimoto | Q63043161 | ||
| Emily G Hamilton | Q88859011 | ||
| Carlo Colantuoni | Q104476353 | ||
| Joshua F Robinson | Q38591070 | ||
| P2093 | author name string | Daniel R Weinberger | |
| Richard E Straub | |||
| Qiang Chen | |||
| Alessandro Bertolino | |||
| Dan Rujescu | |||
| Jan Seidel | |||
| Michael F Egan | |||
| Stefano Marenco | |||
| Karen F Berman | |||
| Gianluca Ursini | |||
| Martin Begemann | |||
| Annamaria Porcelli | |||
| Giovanna Punzi | |||
| Giancarlo Maddalena | |||
| Hidenaga Yanamori | |||
| P2860 | cites work | A systematic review of the prevalence of schizophrenia | Q21144720 |
| A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology | Q21245281 | ||
| Gene × environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution | Q24289449 | ||
| Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 | ||
| Common variants conferring risk of schizophrenia | Q24614376 | ||
| Genotype imputation with thousands of genomes | Q24633967 | ||
| PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
| The genetics of schizophrenia | Q24815806 | ||
| Common polygenic variation contributes to risk of schizophrenia and bipolar disorder | Q28250609 | ||
| Schizophrenia risk from complex variation of complement component 4 | Q28272545 | ||
| HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice | Q28588529 | ||
| Integrative analysis of 111 reference human epigenomes | Q29615565 | ||
| limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
| Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment | Q30407788 | ||
| Prenatal infection and schizophrenia: a review of epidemiologic and translational studies | Q30454666 | ||
| Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets | Q31063920 | ||
| Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders. | Q33733359 | ||
| The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients | Q33743615 | ||
| The placenta: transcriptional, epigenetic, and physiological integration during development | Q33755392 | ||
| Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A. | Q33979177 | ||
| Patches of disorganization in the neocortex of children with autism | Q34040334 | ||
| A polygenic burden of rare disruptive mutations in schizophrenia | Q34060200 | ||
| A linear complexity phasing method for thousands of genomes | Q34237936 | ||
| Perinatal factors and the development of autism: a population study | Q34325419 | ||
| Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort | Q50147773 | ||
| Perinatal Phosphatidylcholine Supplementation and Early Childhood Behavior Problems: Evidence for CHRNA7 Moderation | Q50262185 | ||
| Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. | Q51010260 | ||
| Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. | Q51894967 | ||
| Gender and the course of schizophrenia: differences in treated outcomes. | Q52059683 | ||
| Intrauterine growth restriction: definition and etiology. | Q55067881 | ||
| Pre-eclampsia | Q59546003 | ||
| Obstetric complications as antecedents of schizophrenia: empirical effects of using different obstetric complication scales | Q72117156 | ||
| Obstetric complications in histories of monozygotic twins discordant and concordant for schizophrenia | Q72410407 | ||
| Obstetrical complications and the development of postpartum depressive symptoms: a prospective survey of the MATQUID cohort | Q74666029 | ||
| The cytotrophoblastic shell and complications of pregnancy | Q88394083 | ||
| Large-scale gene function analysis with the PANTHER classification system | Q34358449 | ||
| Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. | Q34366368 | ||
| Obstetric complications and schizophrenia: historical and meta-analytic review | Q34524766 | ||
| Prediction of individual genetic risk to disease from genome-wide association studies | Q34676890 | ||
| Schizophrenia: a concise overview of incidence, prevalence, and mortality | Q34778618 | ||
| Developmental regulation of human cortex transcription and its clinical relevance at single base resolution | Q34797900 | ||
| Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study | Q34923924 | ||
| Software for computing and annotating genomic ranges | Q34945230 | ||
| Haplotype blocks and linkage disequilibrium in the human genome | Q35191477 | ||
| Placental source for 5-HT that tunes fetal brain development | Q35614116 | ||
| Glutamate Networks Implicate Cognitive Impairments in Schizophrenia: Genome-Wide Association Studies of 52 Cognitive Phenotypes | Q35739000 | ||
| Copy number variations of chromosome 16p13.1 region associated with schizophrenia | Q35900760 | ||
| The Placenta as a Mediator of Stress Effects on Neurodevelopmental Reprogramming | Q36366767 | ||
| Childbirth research data: medical records or women's reports? | Q36482902 | ||
| Unexpected complications of low-risk pregnancies in the United States | Q36506114 | ||
| Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex | Q36664812 | ||
| An anthropological perspective on the evolutionary context of preeclampsia in humans | Q36821084 | ||
| BDNF rs6265 methylation and genotype interact on risk for schizophrenia | Q36838967 | ||
| Chromosome conformation elucidates regulatory relationships in developing human brain. | Q37712138 | ||
| Sex differences in schizophrenia | Q37806751 | ||
| Human prefrontal cortex: evolution, development, and pathology | Q37974431 | ||
| An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. | Q37980010 | ||
| Unsupervised Placental Gene Expression Profiling Identifies Clinically Relevant Subclasses of Human Preeclampsia | Q38447616 | ||
| Aberrant maternal inflammation as a cause of pregnancy complications: A potential therapeutic target? | Q38533160 | ||
| Placenta: the forgotten organ | Q38600857 | ||
| Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis | Q38942045 | ||
| Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies. | Q39043919 | ||
| From neuropathology to neurodevelopment | Q40403712 | ||
| Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based study | Q40549028 | ||
| Preeclampsia: an excessive maternal inflammatory response to pregnancy | Q40824430 | ||
| Human evolution: brain, birthweight and the immune system | Q43117822 | ||
| Obstetric conditions and risk of first admission with schizophrenia: a Danish national register based study | Q44074658 | ||
| Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms | Q44453362 | ||
| Maternal Substance Use Disorders and Infant Outcomes in the First Year of Life among Massachusetts Singletons, 2003-2010. | Q46302015 | ||
| Placental programming of anxiety in adulthood revealed by Igf2-null models. | Q47844221 | ||
| Sex differences in the risk of schizophrenia: evidence from meta-analysis | Q47848827 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 792-801 | |
| P577 | publication date | 2018-05-28 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Convergence of placenta biology and genetic risk for schizophrenia | |
| P478 | volume | 24 |
| Q58712902 | A Perspective of the Cross-Tissue Interplay of Genetics, Epigenetics, and Transcriptomics, and Their Relation to Brain Based Phenotypes in Schizophrenia |
| Q99612947 | Alpha7 nicotinic-N-methyl-D-aspartate hypothesis in the treatment of schizophrenia and beyond |
| Q98286217 | Asphyxia at birth affects brain structure in patients on the schizophrenia-bipolar disorder spectrum and healthy participants |
| Q94671562 | Cortical cellular diversity and development in schizophrenia |
| Q89606318 | Cytokine concentrations throughout pregnancy and risk for psychosis in adult offspring: a longitudinal case-control study |
| Q90664324 | Deviations in early hippocampus development contribute to visual hallucinations in schizophrenia |
| Q96133509 | Early magnetic resonance imaging biomarkers of schizophrenia spectrum disorders: Toward a fetal imaging perspective |
| Q89824760 | Examining Gene-Environment Interactions Using Aggregate Scores in a First-Episode Psychosis Cohort |
| Q91790868 | Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study |
| Q93212905 | Genomic updates in understanding PTSD |
| Q64065167 | Human sFLT1 Leads to Severe Changes in Placental Differentiation and Vascularization in a Transgenic hsFLT1/rtTA FGR Mouse Model |
| Q89848243 | Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness |
| Q89014572 | Intersection of schizophrenia genetics and placental complications |
| Q92842012 | Lessons learned by giving amphetamine to antipsychotic-medicated schizophrenia patients |
| Q64114132 | Long-term Risk of Neuropsychiatric Disease After Exposure to Infection In Utero |
| Q91578462 | Male fetus susceptibility to maternal inflammation: C-reactive protein and brain development |
| Q92183304 | Maternal cortisol during pregnancy and offspring schizophrenia: Influence of fetal sex and timing of exposure |
| Q91329654 | Mitochondrial deficits in human iPSC-derived neurons from patients with 22q11.2 deletion syndrome and schizophrenia |
| Q60046972 | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity |
| Q90114172 | Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development |
| Q90111741 | Non-Genetic Factors in Schizophrenia |
| Q92919813 | Obstetric complications and intelligence in patients on the schizophrenia-bipolar spectrum and healthy participants |
| Q90049430 | Perinatal complications and executive dysfunction in early-onset schizophrenia |
| Q90175268 | Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study |
| Q89014282 | Placental gene expression linked to schizophrenia risk |
| Q90018373 | Placental programming of neuropsychiatric disease |
| Q90390597 | Polygenic risk score increases schizophrenia liability through cognition-relevant pathways |
| Q90111580 | Prenatal Maternal Stress and the Cascade of Risk to Schizophrenia Spectrum Disorders in Offspring |
| Q64039342 | Prenatal adverse environment is associated with epigenetic age deceleration at birth and hypomethylation at the hypoxia-responsive EP300 gene |
| Q90707522 | Prenatal and perinatal complications in the development of psychosis: canaries in the coalmine |
| Q90707526 | Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis |
| Q101454094 | Psychological Medicine |
| Q61453582 | Risk taking and impulsive behaviour: fundamental discoveries, theoretical perspectives and clinical implications |
| Q59350417 | Schizophrenia is Associated With an Aberrant Immune Response to Epstein-Barr Virus |
| Q91011100 | Schizophrenia risk variants influence multiple classes of transcripts of sorting nexin 19 (SNX19) |
| Q89435804 | Sex differences in neuroimmunity as an inherent risk factor |
| Q59132940 | Single-Cell Analysis Identifies Thymic Maturation Delay in Growth-Restricted Neonatal Mice |
| Q89488336 | Social Determinants of Placental Health and Future Disease Risks for Babies |
| Q64263103 | The Density of Cell Nuclei at the Materno-Fetal Exchange Barrier is Sexually Dimorphic in Normal Placentas, but not in IUGR |
| Q59127815 | The Emerging Role of Altered d-Aspartate Metabolism in Schizophrenia: New Insights From Preclinical Models and Human Studies |
| Q96302720 | The polygenic architecture of schizophrenia - rethinking pathogenesis and nosology |
| Q61806070 | Treating the "E" in "G × E": Trauma-Informed Approaches and Psychological Therapy Interventions in Psychosis |
| Q57157666 | [A selective review of recent research results in biological psychiatry] |
Search more.